logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > GDC-0077 CAS 2060571-02-8

GDC-0077 CAS 2060571-02-8

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 2060571-02-8

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
2060571-02-8
Appearance::
Solid Powder
Molecular Formula::
C18H19F2N5O4
Molecular Weight::
407.37100
EINECS NO::
NA
MDL NO::
MFCD31382124
CAS NO::
2060571-02-8
Appearance::
Solid Powder
Molecular Formula::
C18H19F2N5O4
Molecular Weight::
407.37100
EINECS NO::
NA
MDL NO::
MFCD31382124
GDC-0077 CAS 2060571-02-8

Product Description:

Product Name: GDC-0077 CAS NO: 2060571-02-8

 

 

Synonyms:

(2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide;

 

 

Chemical & Physical Properties:

Appearance: Solid powder

Assay :≥98.0%

Solubility: DMSO

Storage: Store in a cool and dry place (or refer to the Certificate of Analysis).

 

 

GDC-0077 is an orally available PI3K inhibitor with potential antineoplastic activity. GDC-0077 is extracted from patent WO 2017001645 A1, formula I. GDC-0077 is an orally available and selective PI3K inhibitor (IC50 = 0.038 + 0.003 nM) with > 300-fold selective over other Class I PI3K isoforms. GDC-0077 exerts its activity by binding to the ATP binding site of PI3K, thereby inhibiting the phosphorylation of PIP2 to PIP3.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.